Noumed Pharmaceutical

Noumed Pharmaceutical is a UK based integrated generics pharmaceutical company with a wide range of services and products from manufacturing to development. Noumed Pharmaceutical is developing a $85M generic drug manufacturing plant in Adelaide, South Australia. The proposed plant is located within the Nexus North Industrial Estate, next door to fellow pharmaceutical firm ASX-listed Mayne Pharma. The local plant will produce around 40 million tablets, liquids and creams replacing product currently manufactured in the UK. Bell have been engaged to deliver architectural, interior design and landscape design services. The project is set to commence construction in early 2024.